Renfu Medicine: Subsidiary Withdraws Drug Registration Application.

Renfu Pharmaceutics announced that its holding subsidiary Wuhan Optics Valley Renfu Biopharmaceutical Co., Ltd. recently received a "Notice of Termination of Drug Registration Application" issued by the National Medical Products Administration, agreeing to Wuhan Optics Valley Renfu's withdrawal of the registration application for recombinant plasmid - hepatocyte growth factor injection.